353 related articles for article (PubMed ID: 10431273)
1. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
[TBL] [Abstract][Full Text] [Related]
2. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
3. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study.
Andersen PE; Bolstad B; Berg KJ; Justesen P; Thayssen P; Kloster YF
Clin Radiol; 1993 Oct; 48(4):268-72. PubMed ID: 8243006
[TBL] [Abstract][Full Text] [Related]
4. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
Sutton AG; Ashton VJ; Campbell PG; Price DJ; Hall JA; de Belder MA
Catheter Cardiovasc Interv; 2002 Nov; 57(3):346-52. PubMed ID: 12410513
[TBL] [Abstract][Full Text] [Related]
5. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
Fransson SG; Stenport G; Andersson M
Acta Radiol; 1996 Mar; 37(2):218-22. PubMed ID: 8600966
[TBL] [Abstract][Full Text] [Related]
6. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
[TBL] [Abstract][Full Text] [Related]
7. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography.
Palmers Y; De Greef D; Grynne BH; Smits J; Put E
Eur J Radiol; 1993 Nov; 17(3):203-9. PubMed ID: 8293750
[TBL] [Abstract][Full Text] [Related]
8. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
Bertrand ME; Esplugas E; Piessens J; Rasch W
Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
[TBL] [Abstract][Full Text] [Related]
9. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
10. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial.
Siegel EL; Rosenblum JD; Eckard DA; Leef J; Bergh J; Parsa MB; Redick ML
Acad Radiol; 1996 Sep; 3 Suppl 3():S507-13. PubMed ID: 8883529
[TBL] [Abstract][Full Text] [Related]
11. Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs.
Morris TW; Dukovic D; Pagani E
Acad Radiol; 1995 Jan; 2(1):33-7. PubMed ID: 9419521
[TBL] [Abstract][Full Text] [Related]
12. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
Persson P; Liss P; Hansell P
J Am Coll Cardiol; 2007 Apr; 49(15):1668-1669. PubMed ID: 17433962
[No Abstract] [Full Text] [Related]
14. Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography.
Wisneski JA; Gertz EW; Dahlgren M; Muslin A
Am J Cardiol; 1989 Feb; 63(7):489-95. PubMed ID: 2916435
[TBL] [Abstract][Full Text] [Related]
15. Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
Deray G
J Am Coll Cardiol; 2007 Apr; 49(15):1668. PubMed ID: 17433961
[No Abstract] [Full Text] [Related]
16. Vectorcardiographic changes during cardioangiography with iodixanol and ioxaglate.
Flinck A; Selin K
Int J Cardiol; 2000; 76(2-3):173-80. PubMed ID: 11104872
[TBL] [Abstract][Full Text] [Related]
17. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic changes induced by cardiac angiography with ioxaglate: comparison with diatrizoate.
Hirshfeld JW; Laskey W; Martin JL; Groh WC; Untereker W; Wolf GL
J Am Coll Cardiol; 1983 Nov; 2(5):954-7. PubMed ID: 6630771
[TBL] [Abstract][Full Text] [Related]
19. Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate.
Sapoval MR; Beyssen BM; Girardot C; Musset MA; Legmann P; Brekke O; Gaux JC
Clin Radiol; 1996 Mar; 51(3):210-3. PubMed ID: 8605753
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
Davidson CJ; Laskey WK; Hermiller JB; Harrison JK; Matthai W; Vlietstra RE; Brinker JA; Kereiakes DJ; Muhlestein JB; Lansky A; Popma JJ; Buchbinder M; Hirshfeld JW
Circulation; 2000 May; 101(18):2172-7. PubMed ID: 10801758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
